High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents from 2016 to 2021

Kavya Pathak; Claire Narang; Thomas J. Hwang; Juan C. Espinoza; Florence T. Bourgeois

doi:10.1001/jamapediatrics.2022.4131

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents from 2016 to 2021

Kavya Pathak, Claire Narang, Thomas J. Hwang, Juan C. Espinoza, Florence T. Bourgeois^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	98-100
Number of pages	3
Journal	JAMA Pediatrics
Volume	177
Issue number	1
DOIs	https://doi.org/10.1001/jamapediatrics.2022.4131
State	Published - Jan 3 2023

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1001/jamapediatrics.2022.4131

Cite this

@article{8cb2d487c928423188fd284a41f37b7a,

title = "High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents from 2016 to 2021",

author = "Kavya Pathak and Claire Narang and Hwang, {Thomas J.} and Espinoza, {Juan C.} and Bourgeois, {Florence T.}",

note = "Funding Information: Funding/Support: This work was supported by an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund (grant No. 1017627; Dr Bourgeois). Funding Information: Conflict of Interest Disclosures: Dr Espinoza reported receiving grants from the US Food and Drug Administration during the conduct of the study and personal fees for consulting from AI Health outside the submitted work. Dr Bourgeois reported receiving grants from Burroughs Wellcome Fund and serving as codirector of the Harvard-MIT Center for Regulatory Science. No other disclosures were reported. ",

year = "2023",

month = jan,

day = "3",

doi = "10.1001/jamapediatrics.2022.4131",

language = "English (US)",

volume = "177",

pages = "98--100",

journal = "JAMA Pediatrics",

issn = "2168-6203",

publisher = "American Medical Association",

number = "1",

}

TY - JOUR

T1 - High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents from 2016 to 2021

AU - Pathak, Kavya

AU - Narang, Claire

AU - Hwang, Thomas J.

AU - Espinoza, Juan C.

AU - Bourgeois, Florence T.

N1 - Funding Information: Funding/Support: This work was supported by an Innovation in Regulatory Science Award from the Burroughs Wellcome Fund (grant No. 1017627; Dr Bourgeois). Funding Information: Conflict of Interest Disclosures: Dr Espinoza reported receiving grants from the US Food and Drug Administration during the conduct of the study and personal fees for consulting from AI Health outside the submitted work. Dr Bourgeois reported receiving grants from Burroughs Wellcome Fund and serving as codirector of the Harvard-MIT Center for Regulatory Science. No other disclosures were reported.

PY - 2023/1/3

Y1 - 2023/1/3

UR - http://www.scopus.com/inward/record.url?scp=85145492574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85145492574&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2022.4131

DO - 10.1001/jamapediatrics.2022.4131

M3 - Letter

C2 - 36342722

AN - SCOPUS:85145492574

SN - 2168-6203

VL - 177

SP - 98

EP - 100

JO - JAMA Pediatrics

JF - JAMA Pediatrics

IS - 1

ER -

High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents from 2016 to 2021

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this